NCT01335477 - Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II | Biotech Hunter

Enrollment

551

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Pulmonary Fibrosis

Interventions

DRUG

placebo

placebo matching BIBF 1120 BID

DRUG

BIBF 1120

BIBF 1120 BID (twice daily)

Trial Locations (108)

Unknown

1199.34.10078 Boehringer Ingelheim Investigational Site, Scottsdale

1199.34.10086 Boehringer Ingelheim Investigational Site, San Francisco

1199.34.10093 Boehringer Ingelheim Investigational Site, Santa Barbara

1199.34.10077 Boehringer Ingelheim Investigational Site, Stanford

1199.34.10083 Boehringer Ingelheim Investigational Site, Torrance

1199.34.10080 Boehringer Ingelheim Investigational Site, Stamford

1199.34.10087 Boehringer Ingelheim Investigational Site, South Miami

1199.34.10100 Boehringer Ingelheim Investigational Site, Austell

1199.34.10075 Boehringer Ingelheim Investigational Site, Chicago

1199.34.10069 Boehringer Ingelheim Investigational Site, Olathe

1199.34.10090 Boehringer Ingelheim Investigational Site, Lexington

1199.34.10079 Boehringer Ingelheim Investigational Site, Rochester

1199.34.10067 Boehringer Ingelheim Investigational Site, Chesterfield

1199.34.10066 Boehringer Ingelheim Investigational Site, Lebanon

1199.34.10085 Boehringer Ingelheim Investigational Site, Albany

1199.34.10092 Boehringer Ingelheim Investigational Site, Jamaica

1199.34.10074 Boehringer Ingelheim Investigational Site, Durham

1199.34.10088 Boehringer Ingelheim Investigational Site, Toledo

1199.34.10070 Boehringer Ingelheim Investigational Site, Portland

1199.34.10064 Boehringer Ingelheim Investigational Site, Philadelphia

1199.34.10089 Boehringer Ingelheim Investigational Site, Philadelphia

1199.34.10082 Boehringer Ingelheim Investigational Site, Charleston

1199.34.10095 Boehringer Ingelheim Investigational Site, Longview

1199.34.10060 Boehringer Ingelheim Investigational Site, San Antonio

1199.34.10084 Boehringer Ingelheim Investigational Site, Salt Lake City

1199.34.10101 Boehringer Ingelheim Investigational Site, Colchester

1199.34.10073 Boehringer Ingelheim Investigational Site, Madison

1199.34.02001 Boehringer Ingelheim Investigational Site, Calgary

1199.34.02003 Boehringer Ingelheim Investigational Site, Halifax

1199.34.02002 Boehringer Ingelheim Investigational Site, Hamilton

1199.34.56001 Boehringer Ingelheim Investigational Site, Santiago

1199.34.86056 Boehringer Ingelheim Investigational Site, Beijing

1199.34.86052 Boehringer Ingelheim Investigational Site, Shanghai

1199.34.86054 Boehringer Ingelheim Investigational Site, Shanghai

1199.34.86055 Boehringer Ingelheim Investigational Site, Shanghai

1199.34.86058 Boehringer Ingelheim Investigational Site, Shanghai

1199.34.86051 Boehringer Ingelheim Investigational Site, Shenyang

1199.34.86053 Boehringer Ingelheim Investigational Site, Shenyang

1199.34.86057 Boehringer Ingelheim Investigational Site, Yinchuan

1199.34.35801 Boehringer Ingelheim Investigational Site, Helsinki

1199.34.33004 Boehringer Ingelheim Investigational Site, Dijon

1199.34.33003 Boehringer Ingelheim Investigational Site, Lille

1199.34.33005 Boehringer Ingelheim Investigational Site, Lyon

1199.34.33007 Boehringer Ingelheim Investigational Site, Marseille

1199.34.33002 Boehringer Ingelheim Investigational Site, Montpellier

1199.34.33006 Boehringer Ingelheim Investigational Site, Toulouse

1199.34.49003 Boehringer Ingelheim Investigational Site, Bad Berka

1199.34.49002 Boehringer Ingelheim Investigational Site, Berlin

1199.34.49010 Boehringer Ingelheim Investigational Site, Buch

1199.34.49011 Boehringer Ingelheim Investigational Site, Cologne

1199.34.49005 Boehringer Ingelheim Investigational Site, Coswig

1199.34.49001 Boehringer Ingelheim Investigational Site, Essen

1199.34.49007 Boehringer Ingelheim Investigational Site, Greifswald

1199.34.49009 Boehringer Ingelheim Investigational Site, Immenhausen

1199.34.49006 Boehringer Ingelheim Investigational Site, München

1199.34.49004 Boehringer Ingelheim Investigational Site, Münster

1199.34.30005 Boehringer Ingelheim Investigational Site, Athens

1199.34.30001 Boehringer Ingelheim Investigational Site, Heraklion

1199.34.30004 Boehringer Ingelheim Investigational Site, Larissa

1199.34.30002 Boehringer Ingelheim Investigational Site, Maroussi, Athens

1199.34.30003 Boehringer Ingelheim Investigational Site, Nikaia

1199.34.91051 Boehringer Ingelheim Investigational Site, Ahmedabad

1199.34.91053 Boehringer Ingelheim Investigational Site, Banglore

1199.34.91056 Boehringer Ingelheim Investigational Site, Jaipur

1199.34.91054 Boehringer Ingelheim Investigational Site, Pune

1199.34.91055 Boehringer Ingelheim Investigational Site, Pune

1199.34.81059 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

1199.34.81063 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa

1199.34.81060 Boehringer Ingelheim Investigational Site, Kobe, Hyogo

1199.34.81051 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo

1199.34.81054 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1199.34.81055 Boehringer Ingelheim Investigational Site, Ogaki, Gifu

1199.34.81058 Boehringer Ingelheim Investigational Site, Osaka-Sayama, Osaka

1199.34.81057 Boehringer Ingelheim Investigational Site, Sakai, Osaka

1199.34.81053 Boehringer Ingelheim Investigational Site, Seto, Aichi

1199.34.81052 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

1199.34.81056 Boehringer Ingelheim Investigational Site, Tenri, Nara

1199.34.81062 Boehringer Ingelheim Investigational Site, Tokushima, Tokushima

1199.34.81061 Boehringer Ingelheim Investigational Site, Yonago, Tottori

1199.34.52001 Boehringer Ingelheim Investigational Site, Mexico City

1199.34.31002 Boehringer Ingelheim Investigational Site, Amsterdam

1199.34.31001 Boehringer Ingelheim Investigational Site, Nieuwegein

1199.34.31003 Boehringer Ingelheim Investigational Site, Rotterdam

1199.34.35107 Boehringer Ingelheim Investigational Site, Amadora

1199.34.35105 Boehringer Ingelheim Investigational Site, Coimbra

1199.34.35102 Boehringer Ingelheim Investigational Site, Lisbon

1199.34.35103 Boehringer Ingelheim Investigational Site, Lisbon

1199.34.35101 Boehringer Ingelheim Investigational Site, Porto

1199.34.35106 Boehringer Ingelheim Investigational Site, Vila Nova de Gaia

1199.34.07001 Boehringer Ingelheim Investigational Site, Kazan'

1199.34.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg

1199.34.82002 Boehringer Ingelheim Investigational Site, Bucheon-si

1199.34.82004 Boehringer Ingelheim Investigational Site, Incheon

1199.34.82001 Boehringer Ingelheim Investigational Site, Seoul

1199.34.82003 Boehringer Ingelheim Investigational Site, Seoul

1199.34.82006 Boehringer Ingelheim Investigational Site, Seoul

1199.34.82007 Boehringer Ingelheim Investigational Site, Seoul

1199.34.34001 Boehringer Ingelheim Investigational Site, Barcelona

1199.34.34003 Boehringer Ingelheim Investigational Site, Barcelona

1199.34.34004 Boehringer Ingelheim Investigational Site, Barcelona

1199.34.34005 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat

1199.34.34009 Boehringer Ingelheim Investigational Site, Madrid

1199.34.34008 Boehringer Ingelheim Investigational Site, Seville

1199.34.90003 Boehringer Ingelheim Investigational Site, Ankara

1199.34.90001 Boehringer Ingelheim Investigational Site, Istanbul

1199.34.90005 Boehringer Ingelheim Investigational Site, Istanbul

1199.34.90002 Boehringer Ingelheim Investigational Site, Izmir

1199.34.90004 Boehringer Ingelheim Investigational Site, Izmir